APA
Schadendorf D., Long G. V., Stroiakovski D., Karaszewska B., Hauschild A., Levchenko E., Chiarion-Sileni V., Schachter J., Garbe C., Dutriaux C., Gogas H., Mandalà M., Haanen J. B. A. G., Lebbé C., Mackiewicz A., Rutkowski P., Grob J., Nathan P., Ribas A., Davies M. A., Zhang Y., Kaper M., Mookerjee B., Legos J. J., Flaherty K. T. & Robert C. (20170907). Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. : European journal of cancer (Oxford, England : 1990).
Chicago
Schadendorf Dirk, Long Georgina V, Stroiakovski Daniil, Karaszewska Boguslawa, Hauschild Axel, Levchenko Evgeny, Chiarion-Sileni Vanna, Schachter Jacob, Garbe Claus, Dutriaux Caroline, Gogas Helen, Mandalà Mario, Haanen John B A G, Lebbé Céleste, Mackiewicz Andrzej, Rutkowski Piotr, Grob Jean-Jacques, Nathan Paul, Ribas Antoni, Davies Michael A, Zhang Ying, Kaper Mathilde, Mookerjee Bijoyesh, Legos Jeffrey J, Flaherty Keith T and Robert Caroline. 20170907. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. : European journal of cancer (Oxford, England : 1990).
Harvard
Schadendorf D., Long G. V., Stroiakovski D., Karaszewska B., Hauschild A., Levchenko E., Chiarion-Sileni V., Schachter J., Garbe C., Dutriaux C., Gogas H., Mandalà M., Haanen J. B. A. G., Lebbé C., Mackiewicz A., Rutkowski P., Grob J., Nathan P., Ribas A., Davies M. A., Zhang Y., Kaper M., Mookerjee B., Legos J. J., Flaherty K. T. and Robert C. (20170907). Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. : European journal of cancer (Oxford, England : 1990).
MLA
Schadendorf Dirk, Long Georgina V, Stroiakovski Daniil, Karaszewska Boguslawa, Hauschild Axel, Levchenko Evgeny, Chiarion-Sileni Vanna, Schachter Jacob, Garbe Claus, Dutriaux Caroline, Gogas Helen, Mandalà Mario, Haanen John B A G, Lebbé Céleste, Mackiewicz Andrzej, Rutkowski Piotr, Grob Jean-Jacques, Nathan Paul, Ribas Antoni, Davies Michael A, Zhang Ying, Kaper Mathilde, Mookerjee Bijoyesh, Legos Jeffrey J, Flaherty Keith T and Robert Caroline. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. : European journal of cancer (Oxford, England : 1990). 20170907.